A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.
Saved in:
| Title: | A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile. |
|---|---|
| Authors: | Heidenreich R; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Jasny E; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Kowalczyk A; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Lutz J; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Probst J; IDT Biologika GmbH, Quality Unit Vaccines, Dessau-Roßlau, Germany., Baumhof P; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Scheel B; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Voss S; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Kallen KJ; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Fotin-Mleczek M; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany. |
| Source: | International journal of cancer [Int J Cancer] 2015 Jul 15; Vol. 137 (2), pp. 372-84. Date of Electronic Publication: 2015 Jan 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0215 |
|---|---|
| DOI: | 10.1002/ijc.29402 |
